Leading Research into Head & Neck Cancer

IMG_0338-e1550769217260

Monkees singer Peter Tork, diagnosed with a rare form of head and neck cancer back in 2009, dies at the age of 77

Oracle funds much needed research into new treatments for adenoid cycstic carcinoma

A statement from his family yesterday announced:

"We are all saddened to share the news that Peter Thorkelson -- friend, father, husband, grandfather, philosopher, goofball, entertainer -- died peacefully this morning at a family home in Connecticut. Peter succumbed to a 10 year bout with adenoid cystic carcinoma, a rare cancer of the salivary glands."

Adenoid cystic carcinoma (ACC) is characterised by slow but relentless growth. Unfortunately, the 15 year survival rate is low at 40%. ACC often reoccurs, spreads to the lungs and perineural space (the space surrounding a nerve) and becomes resistant to treatments.

More research is needed to help understand what causes resistance to treatment, how this can be overcome and also find new treatments to help patients suffering with ACC. Oracle is proud to be funding a project at the Institute of Cancer Research looking into new therapeutic options for ACC.

Excitingly, we have just agreed to fund a second project taking place at Brunel University London, also focused on improving survival of patients with ACC. Keep an eye out for more details on this next week.

Follow us

Get in touch

Call 020 3875 8991

Email info@oraclecancertrust.org

Registered-logos-grey

Oracle Cancer Trust is a registered charity in England and Wales (1142037). A company limited by guarantee. Registered company in England and Wales (7125497). Registered address: 10 Parsons Green House, 27 Parsons Green Lane, London SW6 4HH.